http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009117098-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d41624f4c12622605b7048517fe8f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5605fbf2ebc167ccbca56059617624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78e1bc7190a6ec03c8a5c4185440318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b97934c7840823a18cbba4bed4c9786a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b19648eff150b87af0202daa8aa09b7e
publicationDate 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009117098-A1
titleOfInvention Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma
abstract The invention concerns in one embodiment a method of treating glaucoma or elevated intraocular pressure comprising administering a pharmaceutically effective amount of a composition comprising a Complement C1q inhibitor. In another embodiment, the invention concerns a composition for the treatment of elevated intraocular pressure and glaucoma, the composition comprising a pharmaceutically effective amount of a Complement C1q inhibitor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018528169-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011112993-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018081250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019137922-A1
priorityDate 2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019326-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129002180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5315615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405

Total number of triples: 42.